Skip to main content

Table 1 Expression (i. e. staining intensity) of CREB and HLA-G in ccRCC with respect to primary tumor WHO grade

From: Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma

ccRCC WHO grade 1 n (%) WHO grade 2
n (%)
WHO grade 3
n (%)
CREB
 Negative (0) 0 (0.0) 24 (50.0) 24 (50.0)
 Weak (1) 10 (11.5) 58 (66.7) 19 (21.8)
 Moderate (2) 17 (15.9) 75 (70.1) 15 (14.0)
 Strong (3) 15 (21.1) 46 (64.8) 10 (14.1)
Cytoplasmic HLA-G
 Negative (0) 40 (19.9) 126 (62.7) 35 (17.4)
 Weak (1) 6 (9.8) 40 (65.6) 15 (24.6)
 Moderate (2) 2 (3.7) 38 (70.4) 14 (25.9)
 Strong (3) 2 (12.5) 7 (43.8) 7 (43.8)
Membranous HLA-G
 Negative (0) 20 (13.6) 95 (64.6) 32 (21.8)
 Weak (1) 12 (18.8) 45 (70.3) 7 (10.9)
 Moderate (2) 11 (18.0) 35 (57.4) 15 (24.6))
 Strong (3) 7 (11.7) 36 (60.0) 17 (28.3)